Role of endothelin-1 in hypertension

被引:148
作者
Schiffrin, EL [1 ]
机构
[1] Clin Res Inst Montreal, Res Grp Hypertens, MRC Multidisciplinary Res Grp Hypertens, Montreal, PQ H2W 1R7, Canada
关键词
endothelin; hypertension; human essential; coronary artery disease; vascular hypertrophy;
D O I
10.1161/01.HYP.34.4.876
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Endothelin-1 (ET-1) is overexpressed in the vascular wall in certain models of experimental hypertension: deoxycorticosterone acetate salt-treated rats, deoxycorticosterone acetate salt-treated spontaneously hypertensive rats (SHR), stroke-prone SHR, Dahl salt-sensitive rats, angiotensin II-infused rats, and 1-kidney 1 clip Goldblatt rats; it is not overexpressed in SHR, 2-kidney 1-clip hypertensive rats, or L-NAME-treated rats. In hypertensive rats without generalized vascular overexpression, however, expression of ET-1 was often enhanced in intramyocardial coronary arteries, suggesting a role of endothelin in myocardial ischemia in hypertension. In rats overexpressing ET-1, ETA/B and ETA-selective receptor antagonists lowered blood pressure and reduced vascular growth, particularly in small arteries, beyond what could be attributed to blood pressure lowering, suggesting a direct effect of ET-1 on growth. Hypertensive rats treated with endothelin antagonists are protected from stroke and renal injury. The ETA/B antagonist bosentan induced blood-pressure reductions in mildly hypertensive patients similar to those achieved with an angiotensin-converting enzyme inhibitor. Moderately to severely hypertensive patients presented with enhanced expression of prepro-ET-1 mRNA in the endothelium of subcutaneous resistance arteries, suggesting that these stages of hyper-tension may respond particularly well to endothelin antagonism Hypertensive patients with coronary artery disease have increased arterial expression of ET-1, and increased plasma levels of immunoreactive endothelin have been described in black patients. ET-1 plays an important role in atherosclerosis, fur which hypertension is an important risk factor. Thus. ET-1 may be involved in experimental and human hypertension. Endothelin antagonists may prove effective as disease-modifying agents if they are shown clinically, as they are experimentally, to offer target organ protection and reduce lone-term complications of hypertension. This remains to be demonstrated in humans.
引用
收藏
页码:876 / 881
页数:6
相关论文
共 88 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]   Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates [J].
Bartholomeusz, B ;
Hardy, KJ ;
Nelson, AS ;
Phillips, PA .
HYPERTENSION, 1996, 27 (06) :1341-1345
[3]   Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney [J].
Benigni, A ;
Zoja, C ;
Corna, D ;
Orisio, S ;
Facchinetti, D ;
Benatti, L ;
Remuzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :416-423
[4]   A SPECIFIC ENDOTHELIN SUBTYPE-A RECEPTOR ANTAGONIST PROTECTS AGAINST INJURY IN RENAL-DISEASE PROGRESSION [J].
BENIGNI, A ;
ZOJA, C ;
CORNA, D ;
ORISIO, S ;
LONGARETTI, L ;
BERTANI, T ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 44 (02) :440-444
[5]   A role for endothelin ET(A) receptors in regulation of renal function in spontaneously hypertensive rats [J].
Bird, JE ;
Webb, ML ;
Giancarli, MR ;
Chao, CC ;
Dorso, CR ;
Asaad, MM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (01) :183-189
[6]   Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats [J].
Blezer, ELA ;
Nicolay, K ;
Goldschmeding, R ;
Jansen, GH ;
Koomans, HA ;
Rabelink, TJ ;
Joles, JA .
HYPERTENSION, 1999, 33 (01) :137-144
[7]   GROWTH-FACTOR ACTIVITY OF ENDOTHELIN ON VASCULAR SMOOTH-MUSCLE [J].
BOBIK, A ;
GROOMS, A ;
MILLAR, JA ;
MITCHELL, A ;
GRINPUKEL, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03) :C408-C415
[8]   Role of endothelin in the increased vascular tone of patients with essential hypertension [J].
Cardillo, C ;
Kilcoyne, CM ;
Waclawiw, M ;
Cannon, RO ;
Panza, JA .
HYPERTENSION, 1999, 33 (02) :753-758
[9]   INVITRO VASCULAR REACTIVITY TO ENDOTHELIN - A COMPARISON BETWEEN YOUNG AND OLD NORMOTENSIVE AND HYPERTENSIVE RATS [J].
CARGNELLI, G ;
ROSSI, G ;
BOVA, S ;
PESSINA, AC .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1990, 12 (08) :1437-1451
[10]   INTRAVENOUS ERYTHROPOIETIN (RHUEPO) ADMINISTRATION INCREASES PLASMA ENDOTHELIN AND BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS [J].
CARLINI, R ;
OBIALO, CI ;
ROTHSTEIN, M .
AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (02) :103-107